Page last updated: 2024-12-05

carbophenothion

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carbophenothion: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13081
CHEMBL ID452866
CHEBI ID82107
SCHEMBL ID10754
MeSH IDM0049737

Synonyms (115)

Synonym
carbofenothion
oleoakarithion
trithion
dithiophosphate de o,o-diethyle et de (4-chloro-phenyl) thiomethyle
o,o-diethyl s-(p-chlorophenylthio)methyl phosphorodithioate
nsc-231691
r-1303
o,o-dietil-s-((4-cloro-fenil-tio)-metile)-ditiofosfato
o,o-diethyl s-[[(4-chlorophenyl)thio]methyl] dithiophosphate
o,o-diaethyl-s-[(4-chlor-phenyl-thio)methyl]dithiophosphat
r 1303
o,o-diethyl-s-(4-chloor-fenyl-thio)-methyl)-dithiofosfaat
s-[[(4-chlorophenyl)thio]methyl]diethyl phosphorothiolothionate
stauffer r-1303
acarithion
nsc231691
o,o-diethyl s-[[(p-chlorophenyl)thio]methyl] dithiophosphate
wln: 2ops&o2&sr d1sps&o2&o2
trithion miticide
o,o-diethyl [[(p-chlorophenyl)mercapto]methyl] dithiophosphate
carbofenotion
carbophenothion
o,o-diethyl-s-p-chlorfenylthiomethylester kyseliny dithiofosforecne
hexathion
ethyl carbophenothion
786-19-6
garrathion
akarithion
dagadip
o,o-diethyl dithiophosphoric acid p-chlorophenylthiomethyl ester
s-[[(p-chlorophenyl)thio]methyl] o,o-diethyl phosphorodithioate
nephocarp
o,o-diethyl s-[[(p-chlorophenyl)thio]methyl] phosphorodithioate
ent 23,708
carbofenthion
s-{[(4-chlorophenyl)thio]methyl} o,o-diethyl dithiophosphate
lethox
ai3-23708
karbofenothion [czech]
caswell no. 165
s-(((4-chlorophenyl)thio)methyl) o,o-diethyl phosphorodithioate
einecs 212-324-1
epa pesticide chemical code 058102
o,o-diethyl-s-p-chlorfenylthiomethylester kyseliny dithiofosforecne [czech]
phosphorodithioic acid, s-(((p-chlorophenyl)thio)methyl) o,o-diethyl ester
brn 1885240
o,o-dietil-s-((4-cloro-fenil-tio)-metile)-ditiofosfato [italian]
o,o-diaethyl-s-((4-chlor-phenyl-thio)-methyl)dithiophosphat [german]
nsc 231691
o,o-diethyl s-(p-chlorophenylthiomethyl) phosphorodithioate
o,o-diethyl p-chlorophenylmercaptomethyl dithiophosphate
carbophenothion [ansi:bsi:iso]
carbofenotionum [inn-latin]
s-(4-chlorophenylthiomethyl)diethyl phosphorothiolothionate
o,o-diethyl-s-((4-chloor-fenyl-thio)-methyl)-dithiofosfaat [dutch]
stauffer r-1,303
o,o-diethyl s-(4-chlorophenylthiomethyl) dithiophosphate
s-(((p-chlorophenyl)thio)methyl) o,o-diethyl phosphorodithioate
carbofenothion [dutch]
phosphorodithioic acid, s-(((4-chlorophenyl)thio)methyl) o,o-diethyl ester
carbofenotion [inn]
o,o-diethyl s-p-chlorophenylthiomethyl dithiophosphate
hsdb 958
oms 244
dithiophosphate de o,o-diethyle et de (4-chloro-phenyl) thiomethyle [french]
s-((p-chlorophenylthio)methyl) o,o-diethyl phosphorodithioate
endyl
NCGC00166170-01
CHEMBL452866
chebi:82107 ,
C18968
cas-786-19-6
tox21_301426
dtxcid002120
NCGC00255134-01
dtxsid7022120 ,
tox21_113359
carbofenotion, carbophenothion
MLS004712086
smr001550569
carbophenothion [inn:ansi:bsi:iso]
o,o-diethyl-s-((4-chloor-fenyl-thio)-methyl)-dithiofosfaat
o,o-diaethyl-s-((4-chlor-phenyl-thio)-methyl)dithiophosphat
998nga2q61 ,
karbofenothion
carbofenotionum
carbofenotion [inn:ban]
unii-998nga2q61
s-(4-chlorophenylthiomethyl) o,o-diethyl phosphorodithioate
SCHEMBL10754
carbophenothion [hsdb]
carbophenothion [iso]
s-4-chlorophenylthiomethyl o,o-diethyl phosphorodithioate
carbophenothion [mi]
NCGC00166170-02
o,o-diethyl s-(((4-chlorophenyl)thio)methyl) dithiophosphate
trithiontylphenol
o,o-diethyl s-(((p-chlorophenyl)thio)methyl) dithiophosphate
VEDTXTNSFWUXGQ-UHFFFAOYSA-N
phosphorodithioic acid, s-[[(p-chlorophenyl)thio]methyl] o,o-diethyl ester
phosphorodithioic acid, s-[[(4-chlorophenyl)thio]methyl] o,o-diethyl ester
o,o-diaethyl-s-((4-chlor-phenyl-thio)methyl)dithiophosphat
s-([(4-chlorophenyl)sulfanyl]methyl) o,o-diethyl dithiophosphate #
s-(((4-chlorophenyl)thio)methyl)diethyl phosphorothiolothionate
s-(4-chlorophenylthiomethyl) oo-diethyl phosphorodithioate
o,o-diethyl (((p-chlorophenyl)mercapto)methyl) dithiophosphate
SR-01000883724-1
sr-01000883724
carbophenothion, pestanal(r), analytical standard
carbophenothion 100 microg/ml in cyclohexane
carbophenothion 10 microg/ml in isooctane
s-(4-chlorophenylthio)methyl o,o-diethyl phosphorodithioate
Q2937964
mfcd00128009
(4-chlorophenyl)sulfanylmethylsulfanyl-diethoxy-sulfanylidene-lambda5-phosphane

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Guthion and coumaphos, although highly toxic by topical application, were both ineffective as contact insecticides when applied as solids in suspension."( The toxicity of some organophosphorus compounds to adult Anopheles stephensi.
BARLOW, F; HADAWAY, AB, 1963
)
0.24

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Fenthion and malathion were the most promising of the compounds, and wettable powder deposits at a dosage of 1 g/m(2) on plywood remained effective for five months."( The toxicity of some organophosphorus compounds to adult Anopheles stephensi.
BARLOW, F; HADAWAY, AB, 1963
)
0.24
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic sulfideCompounds having the structure RSR (R =/= H). Such compounds were once called thioethers.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency31.62280.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
acetylcholinesteraseHomo sapiens (human)Potency89.35840.002541.796015,848.9004AID1347395
RAR-related orphan receptor gammaMus musculus (house mouse)Potency1.93310.006038.004119,952.5996AID1159521
GLS proteinHomo sapiens (human)Potency10.00000.35487.935539.8107AID624170
GLI family zinc finger 3Homo sapiens (human)Potency48.55770.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency20.88870.000221.22318,912.5098AID1259243; AID1259247
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency19.75160.001022.650876.6163AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency4.85580.000417.946075.1148AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency1.06840.01237.983543.2770AID1645841
retinoid X nuclear receptor alphaHomo sapiens (human)Potency24.54120.000817.505159.3239AID1159527
pregnane X nuclear receptorHomo sapiens (human)Potency10.87070.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.28100.000229.305416,493.5996AID743075; AID743079
GVesicular stomatitis virusPotency0.21320.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency9.52210.00108.379861.1304AID1645840
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.38900.001024.504861.6448AID743212
aryl hydrocarbon receptorHomo sapiens (human)Potency8.25430.000723.06741,258.9301AID743085; AID743122
thyroid stimulating hormone receptorHomo sapiens (human)Potency25.94790.001628.015177.1139AID1224843; AID1259385; AID1259395
Histone H2A.xCricetulus griseus (Chinese hamster)Potency28.38540.039147.5451146.8240AID1224845
DNA polymerase kappa isoform 1Homo sapiens (human)Potency15.00300.031622.3146100.0000AID588579
Interferon betaHomo sapiens (human)Potency0.21320.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency0.21320.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency0.21320.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency0.21320.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (45)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (22)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID409957Inhibition of bovine liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (57.14)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's3 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.61 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index30.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (14.29%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]